Clinical Trials

Transplantation

Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial - EXTended Criteria Donors
PI Dr. Richard Formica
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial
PI Dr. Richard Formica
A Randomized, Open-Label Study to Compare the Safety and Efficacy of Two Different Sirolimus Regimens With a Tacrolimus + Mycophenolte Mofetil regimen in De Novo renal Allograft Recipients
Pi Dr. Sanjay Kulkarni
Noninvasive Monitoring to Predict Outcome in De Novo Kidney Transplant Recipients
Pi Richard Formica
A Randomized, Open-Label, Comparative Evaluation of Conversion from Calcineurin Inhibitors to Sirolimus Versus Continued Use of Calcineurin Inhibitors in Renal Allograft Recipients.
PI Dr. Sanjay Kulkarni
A facilitated access program to provide Everolimus (RAD) for maintenance patients completing therapy in RAD trials in solid organ transplantation (RAD 2401)
Pi Dr. Richard Formica

Open Label, Two-Stage, Phase II Study to Evaluate the Efficacy and Tolerability of ZD6474 in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Carcinoma.
An International, Phase II, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study to Assess the Efficacy of ZD6474 (Zactima) verses Placebo in Subjects with Unresectable Locally Advanced or Metastatic Medullary Thyroid Cancer.